Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/24/2017 04/25/2017 04/26/2017 04/27/2017 04/28/2017 Date
117.66(c) 117.27(c) 116.34(c) 117.42(c) 118.3(c) Last
1 502 994 1 243 008 1 759 118 1 424 441 3 385 430 Volume
+0.82% -0.33% -0.79% +0.93% +0.75% Change
More quotes
Financials ($)
Sales 2017 2 071 M
EBIT 2017 417 M
Net income 2017 147 M
Finance 2017 878 M
Yield 2017 -
Sales 2018 2 567 M
EBIT 2018 767 M
Net income 2018 513 M
Finance 2018 1 722 M
Yield 2018 -
P/E ratio 2017 166,74
P/E ratio 2018 60,70
EV / Sales2017 13,8x
EV / Sales2018 10,8x
Capitalization 29 390 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including... 
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
04/28 VERTEX PHARMACEUTICALS INCORPORATED : INC / MA Management's Discussion and Analy..
04/27 VERTEX PHARMACEUTICALS INCORPORATED : beats Street 1Q forecasts
04/27 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
04/27 VERTEX PHARMACEUTICALS INCORPORATED : Reports First-Quarter 2017 Financial Resul..
04/20 VERTEX PHARMACEUTICALS INCORPORATED : to Announce First Quarter 2017 Financial R..
04/20 VERTEX PHARMACEUTICALS INCORPORATED : New Findings Reported from Vertex Pharmace..
04/13 IRONWOOD PHARMACEUTICALS : Appoints Dr. Christopher Wright as Senior Vice Presid..
04/12 VERTEX PHARMACEUTICALS INCORPORATED : to Announce First Quarter 2017 Financial R..
03/31 VERTEX PHARMACEUTICALS INCORPORATED : Biotech Stocks Under Scanner -- Rexahn Pha..
03/30 VERTEX PHARMACEUTICALS INCORPORATED : Based on new trial data, Vertex to seek ap..
More news
Sector news : Bio Therapeutic Drugs
04/28 REGENERON PHARMACEUTICALS : Sanofi beats profit forecasts, upbeat on prospects f..
04/28DJSanofi 1st-Quarter Net Profit Rises on Sale of Animal-Health Unit
04/27 AMGEN : Cost controls help offset lower Amgen first-quarter drug sales
04/26 New GlaxoSmithKline CEO wants fewer, bigger new drug launches
04/18 Johnson & Johnson first quarter revenue misses estimates; new forecast includ..
More sector news : Bio Therapeutic Drugs
Latest Tweets
05:52aNLI Day: Ian Smith  
03:17aVertex Pharmaceuticals Incorporated's hold rating reiterated at Needham &.. 
01:58aVertex Pharmaceuticals Incorporated $VRTX CEO Sells $18,785,400.00 in Stock  
12:02aVertex Pharmaceuticals Incorporated's outperform rating reiterated at Robert .. 
04/28Vertex Pharmaceuticals Incorporated's outperform rating reiterated at Credit .. 
More tweets
Qtime:82
News from SeekingAlpha
04/28 Vertex Pharmaceuticals (VRTX) Q1 2017 Results - Earnings Call Transcript
04/27 Vertex Pharmaceuticals Incorporated 2017 Q1 - Results - Earnings Call Slides
04/26 Notable earnings after Thursday?s close
04/24 Celgene And Biogen Earnings Could Make Or Break The Biotech Sector
04/20 Protalix BioTherapeutics Is Positioned Well For The Future
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 123 $
Spread / Average Target 3,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Ian F. Smith EVP, Chief Operating & Financial Officer
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
Joshua S. Boger Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..60.58%29 390
AMGEN, INC.11.70%120 105
CELGENE CORPORATION7.17%96 861
GILEAD SCIENCES, INC.-4.27%89 611
REGENERON PHARMACEUTIC..5.83%41 293
ACTELION LTD24.13%28 742
More Results